RenaissanceRe (NYSE:RNR) Reports Strong Q2 CY2026

Reinsurance provider RenaissanceRe (NYSE:RNR) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 13.7% year on year to $2.77 billion. Its non-GAAP profit of $12.92 per share was 10% above analysts’ consensus estimates.

Is now the time to buy RenaissanceRe? Find out by accessing our full research report, it’s free.

Company Overview

Born in Bermuda after the devastating Hurricane Andrew created a crisis in the catastrophe insurance market, RenaissanceRe (NYSE:RNR) provides property, casualty, and specialty reinsurance and insurance solutions to customers worldwide, primarily through intermediaries.

Revenue Growth

Insurance companies generate revenue three ways. The first is the core insurance business itself, represented in the income statement as premiums earned. The second source is investment income from investing the “float” (premiums collected but not yet paid out as claims) in assets such as fixed-income assets and equities. The third is fees from policy administration, annuities, and other value-added services. Luckily, RenaissanceRe’s revenue grew at an incredible 17.1% compounded annual growth rate over the last five years. Its growth beat the average insurance company and shows its offerings resonate with customers, a helpful starting point for our analysis.

We at StockStory place the most emphasis on long-term growth, but within financials, a half-decade historical view may miss recent interest rate changes, market returns, and industry trends. RenaissanceRe’s recent performance shows its demand has slowed significantly as its annualized revenue growth of 3% over the last two years was well below its five-year trend. Note: Quarters not shown were determined to be outliers because they were impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business.

This quarter, RenaissanceRe’s revenue fell by 13.7% year on year to $2.77 billion but beat Wall Street’s estimates by 3.7%.

Net premiums earned made up 88% of the company’s total revenue during the last five years, meaning RenaissanceRe barely relies on non-insurance activities to drive its overall growth.

While insurers generate revenue from multiple sources, investors view net premiums earned as the cornerstone — their direct link to core operations stands in sharp contrast to the unpredictability of investment returns and fees.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Book Value Per Share (BVPS)

Insurance companies are balance sheet businesses, collecting premiums upfront and paying out claims over time. The float (premiums collected but not yet paid out) is invested, creating an asset base supported by a liability structure. Book value per share (BVPS) captures this dynamic by measuring these assets (investment portfolio, cash, reinsurance recoverables) less liabilities (claim reserves, debt, future policy benefits). BVPS is essentially the residual value for shareholders.

We therefore consider BVPS very important to track for insurers and a metric that sheds light on business quality because it reflects long-term capital growth and is harder to manipulate than more commonly-used metrics like EPS.

RenaissanceRe’s BVPS grew at an exceptional 13.7% annual clip over the last five years. BVPS growth has also accelerated recently, growing by 21.3% annually over the last two years from $179.87 to $264.77 per share.

Key Takeaways from RenaissanceRe’s Q2 Results

We were impressed that RenaissanceRe beat analysts’ revenue expectations this quarter. We were also glad its EPS outperformed Wall Street’s estimates. Overall, we think this was a decent quarter with some key metrics above expectations. The market seemed to be hoping for more, and the stock traded down 1.1% to $315.99 immediately after reporting.

So do we think RenaissanceRe is an attractive buy at the current price? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).